Drug intelligence / Profile preview

Etadin

Development stage: Unknown
Lead developer: Ergon Pharmaceuticals
Administration: Oral

Overview

Etadin is an herbal/Ayurvedic medicinal product developed and manufactured by Ergon Pharmaceuticals in Bangladesh. Its primary active ingredient is *Echinacea purpurea* (Echinacea). It is formulated as a capsule and is indicated for the treatment and relief of symptoms associated with the common cold, cough, bronchitis, fever, urinary tract infections, and inflammation of the mouth and throat. As an herbal preparation, it utilizes the natural immunostimulatory and anti-inflammatory properties of Echinacea to combat infections and reduce inflammation.

Brand names: Etadin
Other names: Capsule ETADIN

Beyond the preview

Go deeper on Etadin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Etadin.

Explore the full profile